ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date

Tuesday, November 12, 2019

9:00AM-11:00AM
Abstract Number: 2438
Autoantibody Mediated Salivary Gland Hypofunction in Sjögren’s Syndrome Involves Activation of Innate Immunity and Endothelial Cells
Sjögrenʼs Syndrome – Basic & Clinical Science Poster I
9:00AM-11:00AM
Abstract Number: 2074
Automated Diagnosis Extraction from Electronic Medical Records with Machine Learning Classifiers
Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases
9:00AM-11:00AM
Abstract Number: 2726
Baseline Characteristics and Quality of Life Metrics in Non-Infectious Uveitis
Pediatric Rheumatology – ePoster III: Systemic JIA, Fever, & Vasculitis – ARP
9:00AM-11:00AM
Abstract Number: 2381
Baseline Characteristics Associated with Sustained SDAI Remission Following Treatment with Abatacept in Combination with MTX Compared with Abatacept Placebo in Combination with MTX in ACPA Positive Patients with Early RA
RA – Treatments Poster III: Safety and Outcomes
9:00AM-11:00AM
Abstract Number: 2040
BATF2 Contributes to Interferon Dysregulation in SLE Keratinocytes
SLE – Etiology & Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 2545
Belatacept in Systemic Lupus Erythematosus (SLE) Kidney Transplant Patients
SLE – Clinical Poster III: Treatment
9:00AM-11:00AM
Abstract Number: 2017
Beyond Genes—a Multi-omic Analysis of Monozygotic Twins Discordant for Rheumatoid Arthritis
RA – Etiology & Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 2113
Biological Therapy Is Associated with Faster Recovery and Lower Frequency of Switch Treatment in Patients with Chikungunya Fever
Infection-Related Rheumatic Disease Poster
9:00AM-11:00AM
Abstract Number: 2009
Biomarkers Identified by Serum Inflammatory Profile Analysis to Predict Biologic Treatment Response in Rheumatoid Arthritis Patients
RA – Etiology & Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 2115
BK Polyomavirus Viremia and Viruria in Patients with Autoimmune Connective Tissue Diseases: Impact of Immunosuppressants
Infection-Related Rheumatic Disease Poster
9:00AM-11:00AM
Abstract Number: 2195
BMI Has Minimal Effect on Reduction of Symptoms in Patients with Osteoarthritis of the Knee Treated with Diclofenac 1% Gel
Osteoarthritis – Clinical Poster II
9:00AM-11:00AM
Abstract Number: 2463
Body Composition and Fat Distribution in Patients with Psoriasis or Psoriatic Arthritis
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Psoriatic Arthritis, Clinical Features
9:00AM-11:00AM
Abstract Number: 2599
Body Composition and Nailfold Videocapillaroscopy Patterns in a Cohort of Systemic Sclerosis Patients
Systemic Sclerosis & Related Disorders – Clinical Poster III
9:00AM-11:00AM
Abstract Number: 2068
Body Mass Index and Systemic Corticosteroid Use as Indicators of Disease Burden and Their Influence on the Safety Profile of Certolizumab Pegol Across Indications
Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases
9:00AM-11:00AM
Abstract Number: 2222
Bone Health: An Independent Predictor of Coronary Artery Disease
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster
  • «Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 64
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology